AstraZeneca Biopharmaceutical Manufacturing, Canada

DSM is currently considering new investment, but this may be hampered by increased prices of raw materials used for vitamins.

• 
  DSM Biologics laboratory technician monitoring media preparation.
• 
  PER.C6 cell line for production of recombinant proteins.
• 
  A view of the top of a bioreactor skid.
• 
  DSM technical staff working in clean room facilities.
• 
  A tumbler for use in the production process.
• 
  The vitamin premix plant in Mexico is state-of-the-art.
• 
  DSM is currently considering new investment, but this may be hampered by...
• 
  Vitamin products being packaged; the most sophisticated new technologies were...
• 
  The plant also produces vitamins in traditional forms for the Latin American...

Back to Project Details